Clinical trials for Cervical / Vulvar / Vaginal cancer

51 currently recruiting clinical trials
Phase 1 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Anal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Cervical / Vulvar / Vaginal cancer Small intestine and appendix cancer #NCT06781983
Locally Advanced Metastatic Other mutation 1 2 3 or more
Systemic Treatment-Naive
2 recruiting sites
Innate Pharma
Phase 1 Breast cancer Lung cancer Prostate cancer Colon cancer Rectal cancer Kidney cancer Pancreas cancer Liver and bile duct cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Sarcoma and GIST Thymus cancer Penile cancer and germ cell tumors Cervical / Vulvar / Vaginal cancer #NCT06619587
Locally Advanced Metastatic Metastatic Castration-resistant KRAS G12D 1 2 3 or more
Systemic Treatment-Naive
3 recruiting sites
Genentech, Inc
Phase 1 Cervical / Vulvar / Vaginal cancer #NCT05983432 #2023-506539-14-00
Cohorte cancer du col de l'utérus
Cervical cancer Locally Advanced Metastatic 1 Chemotherapy
Systemic Treatment-Naive
4 recruiting sites
SystImmune Inc.
Phase 1 Breast cancer Lung cancer Colon cancer Rectal cancer Pancreas cancer Endometrial cancer Ovarian / Fallopian tubes / Peritoneum cancer Cervical / Vulvar / Vaginal cancer #NCT06400472 #2024-511238-11-00
NSCLC (Non-Small Cell Lung Cancer) Epithelial ovarian cancer Fallopian tube cancer Primary peritoneal cancer (PPC) Cervical cancer HER2 Negative HR Negative 1 2 3 or more
Systemic Treatment-Naive
3 recruiting sites
Eli Lilly et compagnie
Phase 1 Breast cancer Lung cancer Pancreas cancer Bladder / Urinary Tract / Urethral cancer Stomach and esophageal cancer Ovarian / Fallopian tubes / Peritoneum cancer Head and neck cancer Cervical / Vulvar / Vaginal cancer #NCT04389632
Parties A et B (escalade de dose)
NSCLC (Non-Small Cell Lung Cancer) Stomach Oesogastric junction Esophagus Invasive bladder cancer Epithelial ovarian cancer Squamous NSCLC Non-squamous NSCLC Adenocarcinoma Squamous cell carcinoma Urothelial carcinoma Serous high grade carcinoma (HGSOC) Other HER2 Negative Locally Advanced Metastatic 1 2 3 or more
Systemic Treatment-Naive
3 recruiting sites
Seagen